In terms of health, men and women are not painted with the same brush. This is due not just to their biology but also to social, cultural and economic reasons, which are not always taken into account. Gender stereotypes influence medical practices, research, teaching and patient behaviors, leading to situations of gender inequality and discrimination in the management of and access to healthcare.
The Inserm Ethics Committee and its “Gender and Health Research” Working Group have decided to try to raise the awareness of a wide audience on health inequalities through a series of short films, called Gender and Health: beware of clichés!, co-produced by Inserm, CNRS, and Université Paris-Diderot. CNRS and Université Paris-Diderot are the only higher education establishments in France to have set up structures dedicated to gender equality. The project is also supported by the French Ministry of Higher Education, Research and Innovation.
The 6 one-minute films warn of the stereotypes in six domains of medicine and research: depression, life expectancy, cardiovascular diseases, osteoporosis, pain, and brain imaging. These short films have been designed to raise the awareness of healthcare professionals and patients with a view to promoting greater equality in medicine for the benefit of both sexes.
These videos have been released in the run-up to the “JRS Inserm” international conference, to be held in Paris on November 23, 2017, on the theme “Sex and Gender in Health Care and Research : An Innovative Articulation”
UN Secretary-General Mr Ban Ki-moon has just announced the creation of a “Global Health Crises” Task Force, which will bring together 3 co-leads and 12 members, including Inserm Chairman and CEO Yves Lévy. The Task Force will ensure the implementation and monitoring ...
The respective classifications of the European Patent Office (EPO) and France's National Industrial Property Institute (INPI), which have just published their annual rankings for 2017, have confirmed Inserm's ability to innovate. Inserm placed first among patent applicants in the pharmaceutical sector for ...